NCT00289341 Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. Status COMPLETED Phase PHASE1/PHASE2
NCT00288444 Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer Status TERMINATED Phase PHASE1
NCT00288106 S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT Status TERMINATED Phase N/A
NCT00288080 Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer Status COMPLETED Phase PHASE3
NCT00286793 Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC Status COMPLETED Phase PHASE1/PHASE2
NCT00284752 Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00283829 Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00283803 Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer Status COMPLETED Phase PHASE2
NCT00282906 FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer Status COMPLETED Phase NA
NCT00278993 Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy Status COMPLETED Phase PHASE2
NCT00278070 Metronomic Oral Vinorelbine in Patients With Metastatic Tumors Status COMPLETED Phase PHASE2
NCT00276549 Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00274287 GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere Status COMPLETED Phase PHASE2
NCT00273338 DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) Status TERMINATED Phase PHASE3
NCT00272038 Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00270166 The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy Status COMPLETED Phase PHASE3
NCT00268892 Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer Status COMPLETED Phase PHASE2/PHASE3